WWF-Canada celebrates action plan for future Great Bear Sea
This blueprint will guide the implementation of the world’s largest Indigenous-led, collaboratively developed marine
Globe Newswire6-02-2023, 03:54
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26